Catatonia: Definition, Clinical Features, and Mental Health Relevance

Catatonia is a neuropsychiatric syndrome characterized by a cluster of marked psychomotor disturbances that range from near-complete unresponsiveness and immobility to excessive, purposeless motor activity. The term derives from the Greek kata (down) and tonos (tension), reflecting the muscular rigidity historically associated with the condition. In the DSM-5-TR, catatonia is not classified as an independent disorder but rather as a specifier for other mental disorders (such as schizophrenia, bipolar disorder, or major depressive disorder), as a syndrome attributable to another medical condition, or as "unspecified catatonia" when the underlying cause is unclear.

According to the DSM-5-TR, a diagnosis of catatonia requires the presence of three or more of the following 12 psychomotor features:

• Stupor: No psychomotor activity; minimal responsiveness to the environment
• Catalepsy: Passive maintenance of a posture held against gravity
• Waxy flexibility: Slight, even resistance to repositioning by the examiner
• Mutism: Minimal or no verbal response (excluding known aphasia)
• Negativism: Opposition or no response to instructions or external stimuli
• Posturing: Spontaneous, active maintenance of a posture against gravity
• Mannerism: Odd, exaggerated caricatures of normal actions
• Stereotypy: Repetitive, non-goal-directed movements
• Agitation: Purposeless motor activity not influenced by external stimuli
• Grimacing: Involuntary, sustained facial contortions
• Echolalia: Mimicking another person's speech
• Echopraxia: Mimicking another person's movements

The presentation can fluctuate between retarded (hypokinetic) features — such as stupor, mutism, and catalepsy — and excited (hyperkinetic) features — such as agitation and stereotypy. A dangerous subtype, malignant catatonia, involves autonomic instability, hyperthermia, and altered consciousness, and constitutes a medical emergency.

Catatonia was once considered almost synonymous with schizophrenia, but contemporary research has established that it occurs more frequently in the context of mood disorders — particularly bipolar disorder and major depressive disorder — than in schizophrenia spectrum conditions. Importantly, catatonia also arises from general medical conditions, including autoimmune encephalitis (especially anti-NMDA receptor encephalitis), metabolic disturbances, infections, and neurological disorders. Certain medications, particularly abrupt withdrawal of dopaminergic agents or benzodiazepines, can precipitate catatonic states. Research suggests prevalence rates of approximately 9–17% among individuals admitted to acute psychiatric inpatient units, though the condition remains significantly underdiagnosed.

• Neuroleptic Malignant Syndrome (NMS): A potentially lethal reaction to antipsychotic medications that shares features with malignant catatonia, including rigidity, hyperthermia, and autonomic dysfunction. Some researchers consider NMS a drug-induced form of catatonia.
• Akinetic mutism: A neurological condition involving diminished movement and speech due to brain lesions, which must be differentiated from catatonic stupor.
• Psychomotor retardation: A slowing of thought, speech, and movement seen in severe depression that exists on a continuum with catatonic features.
• Stupor: A state of near-unconsciousness or unresponsiveness that can have neurological, metabolic, or psychiatric origins.

Recognizing catatonia is a critical clinical skill because the condition is both common and treatable, yet frequently missed. Misdiagnosis can have serious consequences: administering antipsychotic medications to a person in a catatonic state can worsen symptoms and precipitate malignant catatonia or NMS. First-line treatment typically involves benzodiazepines (particularly lorazepam), with electroconvulsive therapy (ECT) regarded as highly effective for cases that do not respond to benzodiazepines. Standardized assessment tools such as the Bush-Francis Catatonia Rating Scale (BFCRS) aid in systematic detection. A positive response to a lorazepam challenge — marked clinical improvement after administration — is both diagnostically informative and therapeutically significant. Clinicians across all mental health settings should maintain a high index of suspicion for catatonia, particularly in individuals presenting with sudden mutism, immobility, or refusal to eat or drink.

If someone exhibits sudden onset of immobility, unresponsiveness, unusual posturing, refusal to speak, or purposeless agitation — especially in the context of a known psychiatric or medical condition — urgent medical evaluation is essential. Catatonia can escalate to a life-threatening state involving dehydration, malnutrition, deep vein thrombosis, or autonomic collapse. This is a clinical emergency, not a behavioral choice, and requires prompt professional assessment and treatment.